AGV Discovery;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-;UNIVERSITE DE MONTPELLIER
发明人:
申请号：
EP15306835.8
公开号：
EP3170822A1
申请日:
2015.11.18
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention concerns a compound of formula (I):or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the kinase ERK activity in particular ERK2 activity.
